Structure Therapeutics GPCR
Last Price
52 Week Range
$13.22 - $40.29
Next Earnings Date
Feb 26 2026 (Estimate)
Next Earnings Date
Feb 26 2026 (Est.)
Last Price
GPCR Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Structure Therapeutics Inc. | 10-Q | November 6, 2025 | |
Structure Therapeutics Inc. | 8-K | November 6, 2025 | |
Structure Therapeutics Inc. | S3ASR | August 6, 2025 | |
Structure Therapeutics Inc. | 10-Q | August 6, 2025 | |
Structure Therapeutics Inc. | 8-K | August 6, 2025 | |
Structure Therapeutics Inc. | 8-K | June 25, 2025 | |
Structure Therapeutics Inc. | 10-Q | May 8, 2025 | |
Structure Therapeutics Inc. | 8-K | May 8, 2025 | |
Structure Therapeutics Inc. | ARS | April 24, 2025 | |
Structure Therapeutics Inc. | DEF 14A | April 24, 2025 | |
Structure Therapeutics Inc. | 10-K | February 27, 2025 | |
Structure Therapeutics Inc. | 8-K | February 27, 2025 | |
Structure Therapeutics Inc. | 8-K | December 17, 2024 | |
Structure Therapeutics Inc. | 10-Q | November 13, 2024 | |
Structure Therapeutics Inc. | 8-K | November 13, 2024 | |
Structure Therapeutics Inc. | 8-K | September 17, 2024 | |
Structure Therapeutics Inc. | 8-K | August 27, 2024 | |
Structure Therapeutics Inc. | 10-Q | August 8, 2024 | |
Structure Therapeutics Inc. | 8-K | August 8, 2024 | |
Structure Therapeutics Inc. | 8-K | June 27, 2024 | |
Structure Therapeutics Inc. | 8-K | June 3, 2024 | |
Structure Therapeutics Inc. | 8-K | June 3, 2024 | |
Structure Therapeutics Inc. | 10-Q | May 9, 2024 | |
Structure Therapeutics Inc. | 8-K | May 9, 2024 | |
Structure Therapeutics Inc. | ARS | April 25, 2024 | |
Structure Therapeutics Inc. | DEF 14A | April 25, 2024 | |
Structure Therapeutics Inc. | 10-K | March 8, 2024 | |
Structure Therapeutics Inc. | 8-K | March 8, 2024 | |
Structure Therapeutics Inc. | 8-K | December 18, 2023 | |
Structure Therapeutics Inc. | 10-Q | November 17, 2023 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.